Missed Abortion

¡@
INTRODUCTION ¡@

Background: Missed abortion refers to the clinical situation in which an intrauterine pregnancy is present but no longer developing normally. The gestation would be termed a missed abortion only if the diagnosis of incomplete abortion or inevitable abortion was excluded. The condition may present as an anembryonic gestation (empty sac or blighted ovum) or as fetal demise prior to 20 weeks gestation. Before widespread use of ultrasonography, the term missed abortion was given to pregnancies with no uterine growth over a prolonged period of time, typically 6 weeks. Some authorities feel that more specific, descriptive terms should be used; however, the term missed abortion is still widely used among clinicians and is a commonly used indexing term for MEDLINE and other resources.

¡@

Pathophysiology: Causes of missed abortion generally are the same as those causing spontaneous abortion or early pregnancy failure. Causes include anembryonic gestation (blighted ovum), fetal chromosomal abnormalities, maternal disease, embryonic anomalies, placental abnormalities, and uterine anomalies. Virtually all spontaneous abortions are preceded by missed abortion. A rare exception is expulsion of a normal pregnancy because of a uterine abnormality.

Frequency:
¡@

Mortality/Morbidity:

Race: Incidence is similar among all races.

Age: Pregnancy failure increases with age and rises significantly after age 40.

CLINICAL ¡@

History: History is of limited value. Obtaining information about the first diagnosis of pregnancy, any Human Chorionic Gonadotropin (HCG) tests, or abatement of symptoms of pregnancy may help increase the index of suspicion for the diagnosis of missed abortion.

Physical:

Causes: Causes of missed abortion generally are the same as those causing spontaneous abortion or early pregnancy failure. Causes include anembryonic gestation (blighted ovum), fetal chromosomal abnormalities, maternal disease, embryonic anomalies, placental abnormalities, and uterine anomalies.

DIFFERENTIALS ¡@

Ectopic Pregnancy
Hydatidiform Mole


Other Problems to be Considered:

Normal intrauterine pregnancy
Complete spontaneous abortion
Incomplete abortion
Inevitable abortion
Multiple gestation

WORKUP ¡@

Lab Studies:
¡@

Imaging Studies:
¡@

Other Tests:
¡@

Procedures:
¡@

Histologic Findings: Histologic findings are similar to that of spontaneous abortion. Varying amounts of placental and/or fetal tissue should be present and are usually reported as products of conception.

TREATMENT ¡@

Medical Care: Although missed abortion has been treated surgically in the United States, there have been series of patients treated medically. Both mifepristone (RU 486) and misoprostol have been used to empty the uterus. Some series have offered expectant management to those patients with small amounts of tissue in the uterus. While these regimens generally are successful, a number of women require curettage because of retained tissue or bleeding. For now, medical treatment and expectant management are limited to clinical trials or reserved for the patient who refuses surgical treatment. As experience is gathered, these modes of treatment may become more common; however, surgical therapy remains the standard of care at this time.

Surgical Care: Missed abortion usually is managed with suction curettage, which typically is performed in an outpatient setting. No large studies compare medical versus surgical treatment.

MEDICATION ¡@

Although the risk of Rho(D) alloimmunization is minimal following missed abortion, anti-D immune globulin should be administered to women who are Rho(D) negative. This is not necessary if the father is Rho(D) negative.
¡@

Drug Category: Immunoglobulins -- May decrease autoantibody production, and increase solubilization and removal of immune complexes.

Drug Name
¡@
Rho(D) immune globulin (RhoGAM) -- Suppresses immune response of nonsensitized Rho(D)-negative mothers exposed to Rho(D)-positive blood from the fetus as a result of a fetomaternal hemorrhage, abdominal trauma, amniocentesis, abortion, full-term delivery, or transfusion accident.
Adult Dose <13 wk gestation: 50 mcg within 3 h, but may give within 72 h
>13 wk gestation: 300 mcg
Pediatric Dose Administer as in adults
Contraindications Documented hypersensitivity; patients who have received Rho(D)-positive blood within the last 3 mo
Interactions None reported
Pregnancy C - Safety for use during pregnancy has not been established.
Precautions Caution in thrombocytopenia, bleeding disorders, or IgA deficiency
FOLLOW-UP ¡@

Further Outpatient Care:
¡@

Complications:
¡@

Prognosis:
¡@

Patient Education:
¡@

BIBLIOGRAPHY ¡@